← Back to Search

Contact Lenses

kalifilcon A Daily Disposable Toric for Near-sightedness

N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights

Study Summary

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Baseline Visit at which informed consent will be obtained and eligibility will be assessed.

Eligible Conditions
  • Near-sightedness
  • Astigmatism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: kalifilcon A Daily Disposable ToricExperimental Treatment1 Intervention
kalifilcon A Daily Disposable Toric
Group II: Ultra for Astigmatism Contact LensesActive Control1 Intervention
Ultra for Astigmatism Contact Lenses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
kalifilcon A Daily Disposable Toric
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
251 Previous Clinical Trials
57,388 Total Patients Enrolled
Robert SteffenStudy DirectorBausch & Lomb Incorporated
2 Previous Clinical Trials
835 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025